Lovinger; Ioana

Patent Applications and Registrations

Patent applications and USPTO patent grants for Lovinger; Ioana.The latest application filed is for "high concentration dosage forms of pridopidine".

Company Profile

1.8.23

Lovinger; Ioana - Kfar Saba IL
Lovinger, Ioana - Lod IL

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.

Patent Activity

Patent	Date
High concentration dosage forms of pridopidine Grant 11,452,694 - Licht , et al. September 27, 2	2022-09-27
High Concentration Dosage Forms Of Pridopidine App 20200188305 - LICHT; Danit ; et al.	2020-06-18
Modified Release Formulations Of Pridopidine App 20190209542 - Licht; Daniella ; et al.	2019-07-11
N-ethyl-n-phenyl-1,2-dihydro-4,5-di-hydroxy-1-methyl-2-oxo-3-quinolinecarb- Oxamide, Preparation And Uses Thereof App 20170065576 - Ioffe; Vladimir ; et al.	2017-03-09
Pridopidine Base Formulations And Their Use App 20170020854 - Licht; Danit ; et al.	2017-01-26
N-ethyl-n-phenyl-1,2-dihydro-4,5-di-hydroxy-1-methyl-2-oxo-3-quinolinecarb- Oxamide, Preparation And Uses Thereof App 20160151346 - Ioffe; Vladimir ; et al.	2016-06-02
N-ethyl-n-phenyl-1,2-dihydro-4,5-di-hydroxy-1-methyl-2-oxo-3-quinolinecarb- Oxamide, Preparation And Uses Thereof App 20160151345 - Ioffe; Vladimir ; et al.	2016-06-02
Stable laquinimod preparations Grant 9,340,307 - Safadi , et al. May 17, 2	2016-05-17
N-ethyl-N-phenyl-1,2-dihydro-4,5-di-hydroxy-1-methyl-2-oxo-3-quinolinecarb- oxamide, preparation and uses thereof Grant 9,284,276 - Ioffe , et al. March 15, 2	2016-03-15
Modified Release Formulations Of Pridopidine App 20150202302 - Licht; Daniella ; et al.	2015-07-23
Stable Laquinimod Preparations App 20140024678 - Safadi; Muhammad ; et al.	2014-01-23
Laquinimod Formulations Without Alkalizing Agent App 20140018386 - Sarfati; Gadi ; et al.	2014-01-16
Stable laquinimod preparations Grant 8,545,885 - Safadi , et al. October 1, 2	2013-10-01
N-ethyl-n-phenyl-1,2-dihydro-4,5-di-hydroxy-1-methyl-2-oxo-3-quinolinecarb- Oxamide, Preparation And Uses Thereof App 20130217724 - Ioffe; Vladimir ; et al.	2013-08-22
Stable Laquinimod Preparations App 20120225124 - Safadi; Muhammad ; et al.	2012-09-06
Stable laquinimod preparations Grant 8,178,127 - Safadi , et al. May 15, 2	2012-05-15
Formulations Of Ladostigil Tartrate App 20110301234 - Licht; Daniella ; et al.	2011-12-08
Formulations of ladostigil tartrate Grant 8,022,104 - Licht , et al. September 20, 2	2011-09-20
Stable laquinimod preparations App 20090162432 - Safadi; Muhammad ; et al.	2009-06-25
Formulations of ladostigil tartrate App 20060189685 - Licht; Daniella ; et al.	2006-08-24
Sustained release formulation of N- (2-propylpentanoyl) glycinamide and related compounds App 20040175423 - Licht, Daniella ; et al.	2004-09-09

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.